On May 29, 2019 INmune Bio, Inc. (NASDAQ: INMB), an immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, reported that David Moss, the Company’s co-founder and CFO, will present at the 9th Annual LD Micro Invitational (Press release, INmune Bio, MAY 29, 2019, View Source [SID1234536643]). The event is being held at the Luxe Sunset Boulevard Hotel in Bel-Air, California, on June 4-5, 2019.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The Company is scheduled to present on Wednesday, June 5, 2019 at 10:20 a.m. PT. Management will also be available for one-on-one meetings throughout the event. To schedule a meeting with INmune Bio, please contact KCSA Strategic Communications at [email protected].